Want to see JP:4527 full AI Analyst Report?
Rohto Pharmaceutical Co (4527) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Mesenchymal Stem Cell | Ischemic Heart Disease | Phase II | Not Yet Recruiting | Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG | Aug 28, 2025 | ― |
| Udi-001 | Cerebral Palsy, Periventricular Leukomalacia | phase1AndPhase2 | Completed | A Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy | Apr 30, 2021 | ― |
| Mesenchymal Stem Cell | Severe Acute Respiratory Syndrome Coronavirus 2 | Phase I | Completed | An Exploratory Study of ADR-001 in Patients with Severe Pneumonia Caused by SARS-CoV-2 Infection | Aug 20, 2020 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Mesenchymal Stem Cell | Phase II | Ischemic Heart Disease | Not Yet Recruiting | Exploratory Study of ADR-002K for Heart Failure Patients With Ischemic Heart Disease Who Undergo CABG | Aug 28, 2025 | ― |
| Udi-001 | phase1AndPhase2 | Cerebral Palsy, Periventricular Leukomalacia | Completed | A Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy | Apr 30, 2021 | ― |
| Mesenchymal Stem Cell | Phase I | Severe Acute Respiratory Syndrome Coronavirus 2 | Completed | An Exploratory Study of ADR-001 in Patients with Severe Pneumonia Caused by SARS-CoV-2 Infection | Aug 20, 2020 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Rohto Pharmaceutical Co (JP:4527) have in its pipeline
Rohto Pharmaceutical Co JP:4527 is currently developing the following drugs: Mesenchymal Stem Cell, Udi-001. These drug candidates are in various stages of clinical development as the company works toward FDA approval.